Novartis Sets Eyes on Chinese Vaccine Market
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 11 (Table of Contents)
Published: 11 Nov-2009
DOI: 10.3833/pdr.v2009.i11.1271 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Swiss drug maker, Novartis is to pay US$125 M to acquire 85% of the Chinese vaccine manufacturer, Zhejiang Tianyuan, in its bid to build a strong presence in China...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS